Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the completion of the liquidation and cancellation of its wholly-owned subsidiary
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the acquisition of part of the shares of the Xingong Fund and the non-cash distribution of shares in the Xingong Fund and related transactions
Jinling Pharmaceutical: 2024-093 Announcement of Jinling Pharmaceutical Co., Ltd. on the completion of the cancellation of some restricted stock repurchases
Jinling Pharmaceutical: Legal Opinion on the Implementation of Jinling Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan to Repurchase and Cancel Some Restricted Shares
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Prompt Announcement of Jinling Pharmaceutical Co., Ltd. on the holding of the 4th Extraordinary General Meeting of Shareholders in 2024
Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: Report for the third quarter of 2024
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the progress of the company and its subsidiaries using idle own funds to purchase wealth management products
Jinling Pharmaceutical: Verification Opinions of CITIC Securities Co., Ltd. on the issuance of shares by Jinling Pharmaceutical Co., Ltd. to specific targets and the release of restricted shares from the restricted listing and circulation
Jinling Pharmaceutical: An indicative announcement by Jinling Pharmaceutical Co., Ltd. on issuing some restricted shares to specific targets and releasing restricted listing and circulation
Jinling Pharmaceutical: Announcement of the progress of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised for cash management
Jinling Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the 9th Board of Supervisors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on Jinling Pharmaceutical Co., Ltd.\'s acquisition of part of the Nanjing Xingong Medical Industry Investment Fund Partnership (Limited Partnership) fund shares and related transactions
Jinling Pharmaceutical: Announcement of Resolutions of the 13th Meeting of the 9th Board of Directors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Nanjing Xingong Investment Group Co., Ltd. plans to transfer the asset evaluation report of part of the Nanjing Xingong Medical Industry Investment Fund Partnership (Limited Partnership) fund share project held by Nanjing Xingong Medical Industry Investment Group Co., Ltd. to Jinling Pharmaceutical Co., Ltd.